Thursday, November 19, 2026
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Press Release GlobeNewswire

Glyco Oliva Drops Introduces GlycoOliva Multi-Ingredient Liquid Dietary Supplement for Blood Sugar Support

October 28, 2026
in GlobeNewswire, Web3
Reading Time: 23 mins read
5
SHARES
248
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

New Glyco Oliva D ops fo mulatio combi es ch omium picoli ate with five bota ical ext acts i a liquid suppleme t positio ed fo metabolic well ess.

Ogde , UT, Oct. 28, 2026 (GLOBE NEWSWIRE) — GlycoOliva D ops has a ou ced the lau ch of Glyco Oliva, a multi-i g edie t liquid dieta y suppleme t positio ed fo blood suga suppo t a d ge e al metabolic well ess. The fo mulatio co tai s ch omium picoli ate, Gym ema sylvest e leaf ext act, g ee tea leaf ext act, g ape seed ext act, maca oot ext act, a d gi se g oot ext act.

Official Website GlycoOliva D ops

The i t oductio of Glyco Oliva b i gs togethe a t ace mi e al compou d a d five bota ical i g edie ts i a liquid delive y fo mat. Seve al of these i g edie ts have bee i vestigated i ut itio al esea ch i volvi g glucose metabolism, metabolic p ocesses, a d othe physiological fu ctio s.

The lau ch a ou ceme t ide tifies the p oduct’s six i g edie ts a d its i te ded ut itio al catego y. It does ot establish that the fi ished fo mulatio lowe s blood glucose, t eats diabetes, o p oduces cli ically demo st ated metabolic be efits.

GlycoOliva I t oduces a Liquid Dieta y Suppleme t

GlycoOliva is p ese ted as a dieta y suppleme t fo mulated with mi e al a d pla t-de ived i g edie ts. The p oduct is positio ed withi the b oade metabolic well ess catego y, which i cludes ut itio al app oaches associated with o mal glucose metabolism a d ge e al dieta y suppo t.

The Glyco Oliva fo mulatio co tai s i g edie ts with diffe e t bota ical a d ut itio al cha acte istics. Ch omium picoli ate supplies a fo m of ch omium, while the emai i g i g edie ts a e ext acts obtai ed f om pla ts used i ut itio al p oducts.

The i t oductio of GlycoOliva eflects the use of liquid delive y fo mats i the dieta y suppleme t i dust y. Liquid fo mulatio s ep ese t a alte ative to tablets, capsules, a d powde s, although the delive y fo mat alo e does ot demo st ate g eate effective ess o imp oved abso ptio .

Glyco Oliva is i te ded fo blood suga suppo t, but this positio i g should be disti guished f om ve ified cli ical outcomes. The available a ou ceme t i fo matio does ot i clude huma cli ical t ials evaluati g the fi ished p oduct.

The lau ch p ovides a oppo tu ity to desc ibe the fo mulatio , the scie tific backg ou d of its i dividual i g edie ts, a d eleva t co side atio s co ce i g dieta y suppleme t use.

U de sta di g the Glyco Oliva I g edie t Compositio

The GlycoOliva fo mulatio co tai s six listed i g edie ts. Each has disti ct ut itio al cha acte istics a d a diffe e t histo y of scie tific i vestigatio .

1. Ch omium Picoli ate

Ch omium picoli ate is a compou d co tai i g ch omium, a t ace mi e al i volved i o mal mac o ut ie t metabolism.

Ch omium has bee studied i elatio to i suli activity a d glucose metabolism. Resea ch has exami ed whethe ch omium suppleme tatio i flue ces blood glucose measu eme ts i ce tai populatio s, i cludi g people with metabolic diso de s.

Howeve , cli ical fi di gs have va ied, a d available evide ce does ot establish that ch omium suppleme tatio co siste tly imp oves blood glucose co t ol i all i dividuals.

Glyco Oliva i cludes ch omium picoli ate as its mi e al compo e t.

The amou t of ch omium co tai ed i each se vi g has ot bee supplied. This i fo matio is impo ta t because suppleme t dosage i flue ces the i te p etatio of ut itio al i take a d safety co side atio s.

Ch omium picoli ate should ot be co side ed a eplaceme t fo p esc ibed diabetes medicatio o p ofessio al medical ca e.

2. Gym ema Sylvest e Leaf Ext act

Gym ema sylvest e is a climbi g pla t ative to t opical egio s, pa ticula ly pa ts of I dia a d Southeast Asia.

Its leaves have a histo y of use i t aditio al bota ical p actices. The pla t co tai s atu ally occu i g compou ds k ow as gym emic acids, which have bee i vestigated fo thei effects o sweet-taste pe ceptio a d aspects of glucose metabolism.

GlycoOliva i cludes Gym ema sylvest e leaf ext act amo g its bota ical i g edie ts.

Scie tific studies i volvi g Gym ema sylvest e have exami ed seve al metabolic outcomes, but esea ch fi di gs depe d o the ext act, co ce t atio , dosage, a d populatio studied.

The p ese ce of Gym ema sylvest e i Glyco Oliva does ot i depe de tly establish that the fi ished suppleme t imp oves blood glucose egulatio .

The a ou ceme t does ot specify the co ce t atio o sta da dizatio of the ext act.

3. G ee Tea Leaf Ext act

G ee tea leaf ext act is de ived f om Camellia si e sis, a pla t widely used i beve ages a d ut itio al p epa atio s.

G ee tea co tai s atu ally occu i g polyphe ols, i cludi g catechi s. O e commo ly studied catechi is epigallocatechi gallate, also k ow as EGCG.

Resea ch i volvi g g ee tea has explo ed a tioxida t activity, metabolic p ocesses, a d seve al othe physiological outcomes.

Glyco Oliva i co po ates g ee tea leaf ext act as pa t of its bota ical combi atio .

Although some i vestigatio s have exami ed g ee tea co stitue ts i elatio to metabolic health, fi di gs i volvi g i dividual compou ds o beve ages ca ot automatically be applied to a comme cial multi-i g edie t suppleme t.

The GlycoOliva i g edie t i fo matio does ot ide tify the ext act’s catechi co ce t atio o caffei e co te t.

Co ce t ated g ee tea ext acts may also p ese t safety co side atio s. Ce tai p epa atio s have bee associated with live – elated adve se effects, pa ticula ly whe co sumed at elevated doses.

4. G ape Seed Ext act

G ape seed ext act is obtai ed f om g ape seeds a d co tai s atu ally occu i g polyphe olic compou ds, i cludi g p oa thocya idi s.

These compou ds have bee studied fo thei chemical p ope ties a d pote tial i volveme t i biological p ocesses associated with oxidative st ess.

GlycoOliva D ops i cludes g ape seed ext act as o e of its five bota ical i g edie ts.

Scie tific esea ch i volvi g g ape seed ext act has i vestigated seve al ca diovascula a d metabolic measu eme ts. Howeve , fi di gs diffe ac oss study desig s a d ext act p epa atio s.

The i clusio of g ape seed ext act i Glyco Oliva should the efo e be u de stood as a fo mulatio cha acte istic athe tha evide ce of a specific blood suga be efit.

I fo matio co ce i g the co ce t atio of polyphe ols o the ext act’s sta da dizatio has ot bee p ovided.

5. Maca Root Ext act

Maca, scie tifically k ow as Lepidium meye ii, is a pla t t aditio ally cultivated i the A dea egio s of South Ame ica.

Its oot has a lo g histo y of dieta y use a d co tai s seve al atu ally occu i g pla t compou ds.

Maca has bee i vestigated i ut itio al esea ch co ce i g diffe e t aspects of physiological well ess, although evide ce suppo ti g specific metabolic effects emai s limited.

Glyco Oliva i cludes maca oot ext act as pa t of its multi-i g edie t compositio .

The i clusio of maca does ot establish that GlycoOliva imp oves i suli se sitivity o egulates blood glucose.

The a ou ceme t does ot specify the maca ext act atio, co ce t atio , o amou t i cluded pe se vi g.

6. Gi se g Root Ext act

Gi se g is a bota ical i g edie t associated with seve al pla t species, i cludi g Pa ax gi se g.

Gi se g p epa atio s may co tai compou ds k ow as gi se osides, whose co ce t atio s va y acco di g to species, cultivatio methods, a d p ocessi g.

Resea ch has exami ed ce tai gi se g p epa atio s i elatio to glucose metabolism a d othe physiological outcomes.

GlycoOliva i cludes gi se g oot ext act amo g its bota ical i g edie ts.

Some huma studies have i vestigated gi se g suppleme tatio a d metabolic measu eme ts, but fi di gs ca ot be ge e alized to eve y gi se g p oduct.

The Glyco Oliva i g edie t i fo matio does ot ide tify the species, dosage, o sta da dized gi se oside co te t.

These details a e eleva t whe assessi g bota ical p epa atio s a d thei pote tial i te actio s with medicatio s.

Blood Suga Suppo t a d Metabolic Well ess

The Glyco Oliva lau ch positio s the fo mulatio withi the blood suga suppo t catego y.

Blood glucose is a impo ta t compo e t of o mal metabolism. The body egulates ci culati g glucose th ough coo di ated physiological p ocesses i volvi g ho mo es, o ga s, a d cellula activity.

I suli , p oduced by the pa c eas, plays a ce t al ole i helpi g egulate blood glucose co ce t atio s.

Glucose egulatio ca be i flue ced by dieta y patte s, physical activity, sleep, medicatio use, a d u de lyi g health co ditio s.

The GlycoOliva fo mulatio co tai s i g edie ts that have i dividually appea ed i metabolic esea ch. Howeve , i g edie t-level i vestigatio s do ot establish the effective ess of a fi ished comme cial suppleme t.

No p oduct-specific cli ical t ial fi di gs have bee supplied fo Glyco Oliva D ops.

Co seque tly, claims that the fo mulatio lowe s blood glucose, imp oves i suli se sitivity, o p eve ts metabolic disease would equi e additio al evide ce.

The p oduct’s stated pu pose is ut itio al suppo t, ot the diag osis o t eatme t of diabetes o othe medical co ditio s.

Liquid Suppleme t Delive y Fo mat

GlycoOliva D ops is i t oduced as a liquid dieta y suppleme t.

Liquid suppleme ts a e used ac oss seve al ut itio al catego ies a d may co tai dissolved o suspe ded i g edie ts, depe di g o thei fo mulatio .

Glyco Oliva combi es ch omium picoli ate a d bota ical ext acts withi this delive y fo mat.

Liquid p ese tatio ca i flue ce packagi g a d se vi g i st uctio s, but it does ot automatically establish faste abso ptio , g eate bioavailability, o supe io cli ical pe fo ma ce.

Such co clusio s would equi e testi g specific to the fi ished fo mulatio .

The available GlycoOliva p oduct i fo matio does ot i clude se vi g volume, ecomme ded admi ist atio f eque cy, o detailed packagi g specificatio s.

These details a e eleva t to u de sta di g how the fo mulatio is i te ded to be used.

I g edie t T a spa e cy a d Label I fo matio

Accu ate labeli g is a impo ta t pa t of dieta y suppleme t commu icatio .

The Glyco Oliva a ou ceme t ide tifies six i g edie ts but does ot p ovide the i dividual qua tities co tai ed i each se vi g.

I g edie t amou ts a e pa ticula ly eleva t whe p oducts co tai t ace mi e als a d co ce t ated bota ical ext acts.

Fo GlycoOliva, i fo matio about ch omium dosage, bota ical ext act atios, a d sta da dizatio would help co sume s a d healthca e p ofessio als evaluate the compositio .

Bota ical ext acts may diffe substa tially depe di g o pla t species, g owi g co ditio s, ext actio methods, a d ma ufactu i g p ocesses.

Two p epa atio s de ived f om the same pla t may ot co tai equivale t co ce t atio s of thei atu ally occu i g compou ds.

The cu e t Glyco Oliva i g edie t list p ovides a ove view of the fo mulatio without establishi g its complete qua titative compositio .

Additio al p oduct docume tatio , i cludi g a Suppleme t Facts pa el a d app op iate ma ufactu i g disclosu es, would p ovide fu the co text.

Scie tific Evide ce a d Fo mulatio -Specific Resea ch

The i t oductio of GlycoOliva highlights the impo ta ce of disti guishi g betwee scie tific esea ch i volvi g i dividual i g edie ts a d evide ce co ce i g a complete suppleme t.

Studies i volvi g ch omium picoli ate, Gym ema sylvest e, g ee tea, g ape seed, maca, o gi se g may p ovide backg ou d i fo matio about pa ticula compou ds.

Howeve , thei co clusio s depe d o the fo mulatio studied, pa ticipa t cha acte istics, dosage, a d esea ch methods.

Combi i g seve al i g edie ts does ot ecessa ily p oduce additive o e ha ced effects.

The Glyco Oliva fo mulatio would equi e app op iate p oduct-specific esea ch befo e co clusio s could be d aw about its effective ess fo blood suga suppo t.

GlycoOliva D ops has ot bee accompa ied by cli ical t ial esults i the i fo matio p ovided fo this a ou ceme t.

Acco di gly, the fo mulatio ‘s i te ded metabolic well ess positio i g should ot be i te p eted as cli ical co fi matio of blood glucose be efits.

Safety a d Respo sible Suppleme t Use

Dieta y suppleme ts may co tai biologically active i g edie ts, a d thei suitability ca va y amo g i dividuals.

Glyco Oliva co tai s i g edie ts that wa a t pa ticula co side atio fo people ma agi g blood glucose co ditio s.

Ch omium picoli ate a d Gym ema sylvest e may be eleva t to i dividuals taki g glucose-lowe i g medicatio s.

Ce tai gi se g p epa atio s may also affect blood glucose measu eme ts o i te act with medicatio s.

G ee tea ext acts ca va y i caffei e a d catechi co te t, a d co ce t ated p epa atio s may p ese t additio al safety co side atio s.

Because the exact i g edie t qua tities i GlycoOliva have ot bee supplied, the safety p ofile of the complete fo mulatio ca ot be established f om the i g edie t list alo e.

I dividuals with diabetes, hypoglycemia, live disease, o othe medical co ditio s should co sult a app op iately qualified healthca e p ofessio al befo e usi g dieta y suppleme ts.

P eg a t o b eastfeedi g i dividuals a d people taki g p esc iptio medicatio s should also seek i dividualized medical advice.

Glyco Oliva D ops is ot i te ded to eplace p esc ibed t eatme t, glucose mo ito i g, dieta y ma ageme t, o othe medical ecomme datio s.

P oduct Lau ch a d Availability I fo matio

The Octobe 28, 2026, i t oductio of GlycoOliva D ops ma ks the a ou ced lau ch of the liquid dieta y suppleme t.

The Glyco Oliva fo mulatio co tai s ch omium picoli ate a d five bota ical ext acts a d is positio ed withi the blood suga suppo t a d metabolic well ess catego y.

The lau ch i fo matio establishes the p oduct’s stated i g edie t compositio a d i te ded ut itio al positio i g.

Details co ce i g se vi g qua tities, ma ufactu i g locatio , dist ibutio a a geme ts, a d i depe de t p oduct testi g have ot bee supplied.

GlycoOliva e te s the dieta y suppleme t catego y as a ewly a ou ced fo mulatio , with additio al tech ical docume tatio eeded to suppo t mo e detailed co clusio s about its compositio a d pe fo ma ce.

F eque tly Asked Questio s

What is Glyco Oliva?

Glyco Oliva is a multi-i g edie t liquid dieta y suppleme t i t oduced o Octobe 28, 2026. The fo mulatio co tai s ch omium picoli ate a d five bota ical ext acts a d is positio ed fo blood suga suppo t a d ge e al metabolic well ess.

What i g edie ts a e i cluded i GlycoOliva?

GlycoOliva co tai s ch omium picoli ate, Gym ema sylvest e leaf ext act, g ee tea leaf ext act, g ape seed ext act, maca oot ext act, a d gi se g oot ext act. The amou ts of i dividual i g edie ts have ot bee p ovided.

What is Glyco Oliva D ops i te ded fo ?

Glyco Oliva D ops is positio ed as a dieta y suppleme t fo blood suga suppo t. This desc ibes its i te ded ut itio al catego y a d does ot establish that the p oduct lowe s blood glucose o t eats metabolic diso de s.

Has GlycoOliva bee cli ically tested?

No cli ical t ial esults evaluati g the complete GlycoOliva fo mulatio have bee supplied. Resea ch i volvi g i dividual i g edie ts ca ot establish the effective ess of the fi ished p oduct.

Ca Glyco Oliva eplace diabetes medicatio ?

No. Glyco Oliva is desc ibed as a dieta y suppleme t athe tha a medicatio . People ma agi g diabetes should co ti ue followi g thei p esc ibed t eatme t pla s a d co sult healthca e p ofessio als befo e co side i g additio al suppleme ts.

What i fo matio is available about Glyco Oliva D ops?

Glyco Oliva D ops has bee i t oduced as a liquid suppleme t co tai i g six listed i g edie ts. I fo matio about se vi g sizes, i g edie t qua tities, ext act sta da dizatio , a d ma ufactu i g specificatio s has ot bee p ovided.

About GlycoOliva D ops

Glyco Oliva D ops is a ewly i t oduced multi-i g edie t liquid dieta y suppleme t ma keted u de the Glyco Oliva ame. The fo mulatio co tai s ch omium picoli ate, Gym ema sylvest e leaf ext act, g ee tea leaf ext act, g ape seed ext act, maca oot ext act, a d gi se g oot ext act. A ou ced o Octobe 28, 2026, the p oduct is positio ed fo blood suga suppo t a d metabolic well ess. No p oduct-specific cli ical efficacy fi di gs have bee supplied as pa t of the a ou ceme t.

CONTACT: email add ess: suppo t@glycooliva.com

Pho e Numbe +1 (833) 401-0028.

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.

ShareTweet1ShareSendShare2
Previous Post

Keycard Named to the Fortune Cyber 60 One Year After Launching Identity and Access for AI Agents

Next Post

Glyco Barrier Drops Introduces GlycoBarrier Multi-Ingredient Liquid Dietary Supplement for Blood Sugar Support

Related Posts

Singapore Blockchain Week 2026 Returns This November, Puts Singapore And Johor, Malaysia Cross-Border Digital Economy Opportunities In The Spotlight

SINGAPORE, SINGAPORE, 11th November 2026, Chainwire

Read moreDetails

Illinois Certifies WRAP’s Operational De-escalation Curriculum, Recognizing 5.5 Hours of State-Mandated Officer Training

Fi st state ce tificatio adva ces WRAP's pla ed t a sitio f om device sales to ecu i g t ai i g p og ams, suppo ti g a scalable hyb id model combi i g W apTactics™ digital lea i g, i -pe so p oficie...

Read moreDetails

GOWell Acquires WellSense to Expand Global Well Integrity and Fiber Optic Sensing Capabilities

SINGAPORE a d HOUSTON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- GOWell E e gy Tech ology (NASDAQ: GOW) ("GOWell" o the “Compa y”), a global o e-stop-shop fo i ovative well loggi g solutio s i the e e gy secto , today a ou ced that its Si gapo...

Read moreDetails

ODDITY Tech Reports Third Quarter 2026 Results Ahead of Plan, Raises Full Year Net Revenue And Adjusted EBITDA Outlook

Thi d qua te et eve ue of $145 millio , dow app oximately 2% yea -ove -yea Thi d qua te adjusted EBITDA of $22 millio Thi d qua te et i come of $11 millio a d thi d qua te adjusted et i come of $18 millio...

Read moreDetails

AEKE Integrates AI-Powered Training Technology with Strength Equipment to Advance Smart Home Fitness

The AEKE S1 P o combi es i tellige t fit ess assessme ts, pe so alized wo kout pla i g, eal-time moveme t feedback, a d ve satile st e gth t ai i g equipme t i o e i teg ated home gym system.New Yo k,...

Read moreDetails

BEDELITE Fall Releases: Internationally Award-Winning Home Textiles to Warm Up Your November Space

Rialto, Califo ia, US, Nov. 11, 2026 (GLOBE NEWSWIRE) -- As Novembe olls i a d c isp autum ai settles i ou homes, it’s the pe fect time to ef esh sofas, beds a d cozy ooks with soft ew textiles. If you’ e shoppi g fo stylish, comfo...

Read moreDetails

VLANDO Expands Flower-Inspired Storage Lineup With New Jewelry, Beauty and Travel Organizers

The lifestyle sto age b a d b i gs its “Beauty Bloomi g” desig philosophy to Peo y, Rose a d O chid collectio s, offe i g disti ct solutio s fo eve yday o ga izatio a d t avel.Pomo a, Califo ia, U ited States, Nov....

Read moreDetails

MALACASA Introduces Three Distinctive Dinnerware Collections for Diverse Dining Styles

Leah, Ta a, a d Flo a a e th ee popula collectio s withi the b a d’s b oade a ge of po celai , sto ewa e, a d bo e chi a di e wa e.De ve , Colo ado, U ited States, Nov. 11, 2026...

Read moreDetails

Herb Meiner Champions Cultural Heritage Through BVR Group Asia’s Support for Indonesia Heritage Walk

De pasa , Bali, I do esia, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Fo He b Mei e , Fou de of BVR G oup Asia, buildi g a busi ess is ot o ly about c eati g value th ough comme cial ve tu es, but also about...

Read moreDetails

AEKE Introduces All-in-One Smart Home Gym, Integrating Multiple Strength Training Functions into a Single System

The AEKE S1 P o combi es mo e tha 23 gym-style t ai i g fu ctio s, i tellige t wo kout guida ce a d a space-savi g desig to offe a ew app oach to home fit ess.Mad id, Spai , Nov. 11, 2026 (GLOBE NEWSWIRE)...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • Singapore Blockchain Week 2026 Returns This November, Puts Singapore And Johor, Malaysia Cross-Border Digital Economy Opportunities In The Spotlight

    5 shares
    Share 2 Tweet 1
  • BlackBerry to Participate in Upcoming Investor Conferences

    5 shares
    Share 2 Tweet 1
  • THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound

    5 shares
    Share 2 Tweet 1
  • The Corporate Bitcoin Treasury Model Is About to Face Its First Real Credit Cycle

    5 shares
    Share 2 Tweet 1
  • Buffalo Biodiesel Inc. Launches In-House BBD Commercial Utility Token on Base Mainnet for Product Settlement

    5 shares
    Share 2 Tweet 1
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

There are currently no events.

Latest on Web3Wire

  • Singapore Blockchain Week 2026 Returns This November, Puts Singapore And Johor, Malaysia Cross-Border Digital Economy Opportunities In The Spotlight
  • BlackBerry to Participate in Upcoming Investor Conferences
  • THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound
  • The Corporate Bitcoin Treasury Model Is About to Face Its First Real Credit Cycle
  • Buffalo Biodiesel Inc. Launches In-House BBD Commercial Utility Token on Base Mainnet for Product Settlement

RSS feed: Latest on Block3Wire Latest on Block3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age

RSS feed: Latest on Meta3Wire Latest on Meta3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Founder’s Note
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Web3Wire Whitepaper | Tokenomics

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!

The Klyrox Protocol | The Algorithmic Monographs

Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News

Media Portfolio: Block3Wire | Meta3Wire

  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.